Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance
Abstract
Objective: Familial hyperinsulinemic hypoglycemia type 5 (HHF5) and type A insulin resistance syndrome (TAIRS) are autosomal dominant disorders caused by heterozygous pathogenic variants in the insulin receptor gene (INSR), whereas Rabson-Mendenhall syndrome (RMS) and Donohue syndrome (DS) result from recessive inheritance. We aimed to characterize the metabolic, phenotypic, and genotypic spectrum of individuals with PGV-INSR presenting with hyperinsulinemic hypoglycemia (HH) and insulin resistance (IR).
Methods: Normal-weight probands with HH and IR underwent exome sequencing with familial segregation confirmed by Sanger sequencing. Metabolic evaluation included prolonged fasting, mixed-meal, and oral glucose tolerance tests. A published insulinoma cohort served as a comparator.
Results: Five unrelated families (F1-F5) harbored four heterozygous and one homozygous PGV-INSR. Eighteen carriers were identified. HH occurred in 78% (18/23), predominantly postprandial, whereas 22% had diabetes; IR was present in all carriers and 60% of women had PCOS. Marked intrafamilial variability and phenotypic overlap among HHF5, TAIRS, and RMS were observed, including the coexistence of dominant and recessive inheritance within one family. A distinct metabolic signature was identified, characterized by normal BMI, variable degrees of IR (with or without acanthosis), inappropriately elevated fasting and stimulated insulin concentrations, normal triglycerides, and predominantly postprandial…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.